Investigation of the Impact of Wellinks on the Quality of Life and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease: Interventional Research Study.

Kerri A Pierz¹, Nicholas Locantore², Gretchen McCreary², Robert J Calvey¹, Nickole Hackney¹, Pooja Doshi¹, John Linnell², Abirammy Sundaramoorthy¹, Carol R Reed¹, Julie Yates²

¹Wellinks (Convexity Scientific, Inc), New Haven, CT, United States.

²COPD Foundation, Miami, FL, United States.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Wellinks is a remote disease management solution that provides novel chronic obstructive pulmonary disease (COPD) care delivery. OBJECTIVE: This study evaluated the satisfaction, engagement, and clinical outcomes of Wellinks participants. This study also investigated the cadence of health coaching for patients with COPD. METHODS: A 24-week interventional study was conducted by Wellin…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.